Sort by
Refine Your Search
-
. Eligibility A PhD degree in the field of structural biology and biological and/or protein engineering obtained in a preclinical research environment. Hands-on research experience in biochemical and biophysical
-
of in vitro and in vivo model systems aimed at studying metabolism. Expertise in analysis of omics data. A PhD in a medical/biological subject (to be completed in 2024 at the latest). The ability
-
protocols and experimental techniques. Selection Criteria Essential The person appointed should have a PhD in a relevant field. Experience in common programming languages, e.g., R/Python, and operating
-
to the group at established meetings. Act as a source of information and advice to other members of the group on scientific protocols and experimental techniques. Selection Criteria Essential A PhD in a medical
-
. Selection Criteria Essential A PhD in a medical/biological subject (to be completed in 2024). The ability to manage your own academic research and associated activities. A strong CV, having published in high
-
the last three years, if there are special reasons, your degree may have been completed earlier. The selected applicant needs to have the following qualifications: PhD degree in relevant research area, i.e
-
companies whose commercial algorithms we can explore, along with academic research models. Do you have a PhD or will obtain one in the next few months? Is the PhD in Biostatistics or Bioinformatics or similar
-
fostered. Within C3T we constitute a multi-disciplinary group of experimentalists, lab technicians, computational biologists, developers, PhD students and researchers of various background. We always aim
-
for understanding the mechanisms underlying autoimmune diseases. The applicant should hold a PhD in medicine, immunology, biotechnology, or other relevant area. Experience in cellular and serological immune assays
-
research group in Neuroepidemiology which consists of clinicians, researchers, postdoctoral fellows and PhD students. We are an exciting group working at the intersection between immunology, epidemiology and